The Properties of Lauric Acid and Their Significance in Coconut Oil

  • Fabian M. DayritEmail author


The primary fatty acid of coconut oil is lauric acid, which is present at approximately 45–53 %. The metabolic and physiological properties of lauric acid account for many of the properties of coconut oil. Coconut oil is rapidly metabolized because it is easily absorbed and lauric acid is easily transported. Detailed studies have shown that the majority of ingested lauric acid is transported directly to the liver where it is directly converted to energy and other metabolites rather than being stored as fat. Such metabolites include ketone bodies, which can be used by extrahepatic tissues, such as the brain and heart, as an immediate form of energy. Studies on the effect of lauric acid on serum cholesterol are contradictory. Among saturated fatty acids, lauric acid has been shown to contribute the least to fat accumulation. Lauric acid and monolaurin have demonstrably significant antimicrobial activity against gram positive bacteria and a number of fungi and viruses. Today there are many commercial products that use lauric acid and monolaurin as antimicrobial agents. Because of the significant differences in the properties of lauric acid relative to longer chain fatty acids, they are typically differentiated as medium-chain fatty acids covering C6–C12, and long-chain fatty acids covering C14 and longer.


Coconut oil Lauric acid Medium-chain fatty acid Medium-chain triglyceride Monolaurin 

Symbols and abbreviations


Caproic acid


Caprylic acid


Capric acid


Lauric acid


Myristic acid


Palmitic acid


Stearic acid


Oleic acid


Linoleic acid


Linolenic acid


Long-chain fatty acid(s)


Long-chain triglyceride(s)


Medium-chain fatty acid(s)


Medium-chain triglyceride(s)


1-Monolaurin, 1-monolauryl glyceride


2-Monolaurin, 2-monolauryl glyceride




  1. 1.
    Food and Agriculture Organization of the United Nations (Accessed Feb 2014) FAOSTAT.
  2. 2.
    Spitz L (1990) Soap technology for the 1990s. AOCS Press, ChampaignGoogle Scholar
  3. 3.
    Harkins RW, Sarett HP (1968) Medium-Chain Triglycerides. J Am Med Assoc 203(4):272–274 Note: HP Sarett was from Mead-JohnsonCrossRefGoogle Scholar
  4. 4.
    MCT Oil is a registered trade mark of Nestle and is a dietetic food which contains mainly C8 and C10Google Scholar
  5. 5.
    Bach AC, Babayan VK (1982) Medium-chain triglycerides: an update. Am J Clin Nutr 36:950–962Google Scholar
  6. 6.
    Codex standard for named vegetable oils 1999. (Accessed February 2014) CODEX STAN 210-1999…/CXS_210e.pdf
  7. 7.
    Bezard J, Bugaut M, Clement G (1971) Triglyceride composition of coconut oil. J Am Oil Chem Soc 48:134–139CrossRefGoogle Scholar
  8. 8.
    Marina AM, Che Man YB, Nasimah SAH, Amin I (2009) Chemical properties of virgin coconut oil. J Am Oil Chem Soc 86:301–307CrossRefGoogle Scholar
  9. 9.
    Pham LJ, Casa EP, Gregorio MA, Kwon DY (1998) Triacylglycerols and regiospecific fatty acid analyses of Philippine seed oils. J Am Oil Chem Soc 75(7):807–811CrossRefGoogle Scholar
  10. 10.
    Pham et al. (1998)Google Scholar
  11. 11.
    Dayrit FM, Buenafe OEM, Chainani ET, De Vera IMS (2008) Analysis of monoglycerides, diglycerides, sterols, and free fatty acids in coconut (Cocos nucifera L.) oil by 31P NMR spectroscopy. J Agric Food Chem 56:5765–5769CrossRefGoogle Scholar
  12. 12.
    Bezard JA (1971) The component triglycerides of palm-kernel oil. Lipids 6(9):630–634CrossRefGoogle Scholar
  13. 13.
    Karupaiah T, Sundram K (2007) Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. Nutr Metab 4:16. doi: 10.1186/1743-7075-4-16 CrossRefGoogle Scholar
  14. 14.
    Bracco U (1994) Effect of triglyceride structure on fat absorption. Am J Clin Nutr 60(suppl):1002S–1009SGoogle Scholar
  15. 15.
    Decker EA (1996) The role of stereospecific saturated fatty acid positions on lipid nutrition. Nutr Rev 54(4):108–110CrossRefGoogle Scholar
  16. 16.
    Pham et al. (1998)Google Scholar
  17. 17.
    Porsgaard T, Høy CE (2000) Lymphatic transport in rats of several dietary fats differing in fatty acid profile and triacylglycerol structure. J Nutr 130:1619–1624Google Scholar
  18. 18.
    Pham et al. (1998)Google Scholar
  19. 19.
    Bragdon JH, Karmen A (1960) The fatty acid composition of chylomicrons of chyle and serum following the ingestion of different oils. J Lipid Res 1(2):167–170Google Scholar
  20. 20.
    Swift LL, Hill JO, Peters JC, Greene HL (1990) Medium-chain fatty acids: evidence for incorporation into chylomicron triglycerides in humans. Am J Clin Nutr 52:834–836Google Scholar
  21. 21.
    Bach & Babayan (1982)Google Scholar
  22. 22.
    McDonald GB, Saunders DR, Weidman M, Fisher L (1980) Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am J Physiol 239:G141–G150Google Scholar
  23. 23.
    Goransson G (1965) The metabolism of fatty acids in the rat VIII. Lauric acid and myristic acid. Acta Physiol Scand 64:383–386CrossRefGoogle Scholar
  24. 24.
    Porsgaard and Høy (2000)Google Scholar
  25. 25.
    Debois D, Bralet MP, Le Naour F, Brunelle A, Laprevote O (2009) In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF–SIMS imaging. Anal Chem 81:2823–2831CrossRefGoogle Scholar
  26. 26.
    Garlid KD, Orosz DE, Modriansky M, Vassanelli S, Jezek P (1996) On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein. J Biol Chem 271(5):2615–2620CrossRefGoogle Scholar
  27. 27.
    Hamilton JA (1998) Fatty acid transport: difficult or easy? J Lipid Res 39:467–481Google Scholar
  28. 28.
    Bremer J (1983) Carnitine-metabolism and functions. Physiol Rev 63(4):1420–1466Google Scholar
  29. 29.
    Wanders RJA, Vreken P, Den Boer MEJ, Wijburg FA, Van Gennip AH, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inher Metab Dis 22:442–487CrossRefGoogle Scholar
  30. 30.
    Bach A, Weryha A, Schirardin H (1979) Influence of oral MCT or LCT load on glycemia in Wistar and Zucker rats and in guinea pigs. Ann Biol Anim Biochem Biophys 19(3A):625–635CrossRefGoogle Scholar
  31. 31.
    Adas F, Berthou F, Picart D, Lozac’h P, Beaugé F, Amet Y (1998) Involvement of cytochrome P450 2E1 in the (ω–1)-hydroxylation of oleic acid in human and rat liver microsomes. J Lipid Res 39:1210–1219Google Scholar
  32. 32.
    Jansen EHJM, De Flutter P (1992) Determination of lauric acid metabolites in peroxisome proliferation after derivatization and HPLC analysis with fluorimetric detection. J Liq Chromatogr 15(13):2247–2260CrossRefGoogle Scholar
  33. 33.
    Clarke SE, Baldwin SJ, Bloomer JC, Ayrton AD, Sozio RS, Chenery RJ (1994) Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem Res Toxicol 7(6):836–842CrossRefGoogle Scholar
  34. 34.
    Amet Y, Berthou F, Goasduff T, Salaun JP, Le Breton L, Menez JF (1994) Evidence that cytochrome P450 2E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Commun 203(2):1168–1174CrossRefGoogle Scholar
  35. 35.
    Rioux V, Daval S, Guillou H, Jan S, Legrand P (2003) Although it is rapidly metabolized in cultured rat hepatocytes, lauric acid is used for protein acylation. Reprod Nutr Dev 43:419–430CrossRefGoogle Scholar
  36. 36.
    Drake DR, Brogden KA, Dawson DV, Wertz PW (2008) Antimicrobial lipids at the skin surface. J Lipid Res 49:4–11CrossRefGoogle Scholar
  37. 37.
    Kezutyte T, Desbenoit N, Brunelle A, Briedis V (2013) Studying the penetration of fatty acids into human skin by ex vivo TOF–SIMS imaging. Biointerphases 8:3. doi: 10.1186/1559-4106-8-3 CrossRefGoogle Scholar
  38. 38.
    Decker EA (1996) The role of stereospecific saturated fatty acid positions on lipid nutrition. Nutr Rev 54(4):108–110CrossRefGoogle Scholar
  39. 39.
    Keys A (1957) Diet and the epidemiology of coronary heart disease. J Am Med Assoc 164(17):1912–1919CrossRefGoogle Scholar
  40. 40.
    Keys A, Anderson JT, Grande F (1965) Serum cholesterol response to changes in the diet IV. Particular saturated fatty acids in the diet. Metabolism 14(7):776–787CrossRefGoogle Scholar
  41. 41.
    Hashim SA, Arteaga A, Van Itallie TB, Cozanitis DA (1960) Effect of a saturated medium-chain triglyceride on serum lipids in man. Lancet 1:1105–1108CrossRefGoogle Scholar
  42. 42.
    German JB, Dillard CJ (2004) Saturated fats: what dietary intake? Am J Clin Nutr 80:550–559Google Scholar
  43. 43.
    Denke MA (2006) Dietary Fats, fatty acids, and their effects on lipoproteins. Curr Atheroscler Rep 8:466–471CrossRefGoogle Scholar
  44. 44.
    Tholstrup T, Hjerpsted J, Raff M (2011) Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr 94:1426–1432CrossRefGoogle Scholar
  45. 45.
    Kaunitz H (1970) Nutritional properties of coconut oil. J Am Oil Chem Soc 47:462A–485ACrossRefGoogle Scholar
  46. 46.
    Shorland FB, Czochanska Z, Prior IAM (1969) Studies on fatty acid composition of adipose tissue and blood lipids of Polynesians. Am J Clin Nutr 22(5):594–605Google Scholar
  47. 47.
    Prior IAM, Davison F, Salmonel EF, Czochaska Z (1981) Cholesterol, coconuts and diet in Polynesian atolls—a natural experiment: Pukapuka and Tokelau islands studies. Am J Clin Nutr 34:1552–1561Google Scholar
  48. 48.
    Florentino RF, Aguinaldo AR (1987) Diet and cardiovascular disease in the Philippines. Philipp J Coconut Stud 13(2):56–70Google Scholar
  49. 49.
    Liberato MV, Nascimento AS, Ayers SD, Lin JZ, Cvoro A et al (2012) Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR)γ activators and pan-PPAR partial agonists. PLoS One 7(5):e36297. doi: 10.1371/journal.pone.0036297 CrossRefGoogle Scholar
  50. 50.
    Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 94:4318–4323CrossRefGoogle Scholar
  51. 51.
    Shabalina IG, Backlund EC, Bar-Tana J, Cannon B, Nedergaard J (2008) Within brown-fat cells, UCP1-mediated fatty acid-induced uncoupling is independent of fatty acid metabolism. Biochim Biophys Acta 1777:642–650CrossRefGoogle Scholar
  52. 52.
    Blesneac I, Ravaud S, Machillot P, Zoonens M, Masscheylen S, Miroux B, Vivaudou M, Pebay-Peyroula E (2012) Assaying the proton transport and regulation of UCP1 using solid supported membranes. Eur Biophys J 41:675–679CrossRefGoogle Scholar
  53. 53.
    Samartsev V, Marchik E, Shamagulova L (2011) Free fatty acids as inducers and regulators of uncoupling of oxidative phosphorylation in liver mitochondria with participation of ADP/ATP- and aspartate/glutamate-antiporter. Biochem 76(2):217–224Google Scholar
  54. 54.
    Fedorenko A, Lishko PV, Kirichok Y (2012) Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 151(2):400–413CrossRefGoogle Scholar
  55. 55.
    DeLany JP, Windhauser MM, Champagne CM, Bray GA (2000) Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr 72(4):905–911Google Scholar
  56. 56.
    Galbraith H, Miller TB, Paton AM, Thompson JK (1971) Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol. J Appl Bact 34(4):803–813CrossRefGoogle Scholar
  57. 57.
    Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP (1972) Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 2(1):23–28CrossRefGoogle Scholar
  58. 58.
    Kabara et al. (1972)Google Scholar
  59. 59.
    Kabara JJ (1979) Toxicological, bactericidal and fungicidal fatty acids and some derivatives. J Am Oil Chem Soc 56:760A–767ACrossRefGoogle Scholar
  60. 60.
    Hornung B, Amtmann E, Sauer G (1994) Lauric acid inhibits the maturation of vesicular stomatitis virus. J Gen Virol 75:353–361CrossRefGoogle Scholar
  61. 61.
    Galbraith H, Miller TB (1973) Effect of metal cations and pH on the antibacterial activity and uptake of long chain fatty acids. J Appl Bact 36(4):635–646CrossRefGoogle Scholar
  62. 62.
    Galbraith H, Miller TB (1973) Physicochemical effects of long chain fatty acids on bacterial cells and their protoplasts. J Appl Bact 36(4):647–658CrossRefGoogle Scholar
  63. 63.
    Schuster GS, Dirksen TR, Ciarlone AE, Burnett GW, Reynolds MT, Lankford MT (1980) Anticaries and antiplaque potential of free-fatty acids in vitro and in vivo. Pharmacol Ther Dent 5(1–2):25–33Google Scholar
  64. 64.
    Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP (1992) Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother 36(3):626–631CrossRefGoogle Scholar
  65. 65.
    Projan SJ, Brown-Skrobot S, Schlievert PM, Vandenesch F, Novick RP (1994) Glycerol monolaurate inhibits the production of β-lactamase, toxic shock syndrome toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J Bact 176(14):4204–4209Google Scholar
  66. 66.
    Ruzin A, Novick RP (2000) Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J Bact 182(9):2668–2671CrossRefGoogle Scholar
  67. 67.
    Sun CQ, O’Connor CJ, Roberton AM (2003) Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 36:9–17CrossRefGoogle Scholar
  68. 68.
    Petschow BW, Batema RP, Ford LL (1996) Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 40(2):302–306Google Scholar
  69. 69.
    Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H (2001) In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 45(11):3209–3212CrossRefGoogle Scholar
  70. 70.
    Bartolotta S, Garcí CC, Candurra NA, Damonte EB (2001) Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol 146(4):777–790CrossRefGoogle Scholar
  71. 71.
    Skrivanova E, Marounek M, Dlouha G, Kanka J (2005) Susceptibility of Clostridium perfringens to C2–C18 fatty acids. Lett Appl Microbiol 41:77–81CrossRefGoogle Scholar
  72. 72.
    Kitahara T, Aoyama Y, Hirakata Y, Kamihira S, Kohno S, Ichikawa N, Nakashima M, Sasaki H, Higuchi S (2006) In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 27:51–57CrossRefGoogle Scholar
  73. 73.
    Kabara JJ (1978) Structure-function relationships of surfactants as antimicrobial agents. J Soc Cosmet Chem 29:733–741Google Scholar
  74. 74.
    Lin YC, Schlievert PM, Anderson MJ, Fair CL, Schaefers MM et al (2009) Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 In Vitro and In Vivo. PLoS One 4(10):e7499. doi: 10.1371/journal.pone.0007499 CrossRefGoogle Scholar
  75. 75.
    Ruzin & Novick (2000)Google Scholar
  76. 76.
    Chu-Kung AF, Bozzelli KN, Lockwood NA, Haseman JR, Mayo KH, Tirrell MV (2004) Promotion of peptide antimicrobial activity by fatty acid conjugation. Biocon Chem 15:530–535CrossRefGoogle Scholar
  77. 77.
    Nobmann P, Smith A, Dunne J, Henehan G, Bourke P (2009) The antimicrobial efficacy and structure activity relationship of novel carbohydrate fatty acid derivatives against Listera spp. and food spoilage microorganisms. Int J Food Microbiol 128:440–445CrossRefGoogle Scholar
  78. 78.
    Watanabe T, Katayama S, Matsubara M, Honda Y, Kuwahara M (2000) Antibacterial carbohydrate monoesters suppressing cell growth of streptococcus mutans in the presence of sucrose. Curr Microbiol 41(3):210–213CrossRefGoogle Scholar
  79. 79.
    Kim Y-S, Kim H, Jung E, Kim J-H, Hwang W, Kang E-J, Lee S, Ha B-J, Lee J, Park D (2012) A novel antibacterial compound from Siegesbeckia glabrescens. Molecules 17:12469–12477. doi: 10.3390/molecules171112469 CrossRefGoogle Scholar
  80. 80.
    Yuhas R, Pramuk K, Lien EL (2006) Human milk fatty acid composition from nine countries varies most in DHA. Lipids 41(9):851–858CrossRefGoogle Scholar
  81. 81.
    Newburg DS, Walker WA (2007) Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61:2–8CrossRefGoogle Scholar
  82. 82.
    Batovska DI, Todorova IT, Tsvetkova IV, Najdenski HM (2009) Antibacterial study of the medium chain fatty acids and their 1-monoglycerides: individual effects and synergistic relationships. Pol J Microbiol 58(1):43–47Google Scholar
  83. 83.
    Buňková L, Buňka F, Janiš R, Krejčí J, Doležálková I, Pospíšil Z, Růžička J, Tremlová B (2011) Comparison of antibacterial effect of seven 1-monoglycerides on food-borne pathogens or spoilage bacteria. Acta Vet Brno 80:29–39CrossRefGoogle Scholar
  84. 84.
    Eshghjoo S, Mahdavi S, Daustani M, Ahmadi R, Razavi SM, and Neyriz M (2013) The effects of monolaurin on E. coli O157:H7 growth in dairy food products. 4th international conference on medical, biological and pharmaceutical sciences (ICMBPS’2013), Dubai (UAE) 6–7 Oct 2013Google Scholar
  85. 85.
    Kelsey JA, Bayles KW, Shafii B, McGuire MA (2006) Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 41(10):951–961CrossRefGoogle Scholar
  86. 86.
    Skrivanova et al. (2005)Google Scholar
  87. 87.
    Peterson ML, Schlievert PM (2006) Glycerol monolaurate inhibits the effects of gram-positive select agents on eukaryotic cells. Biochemistry 45(7):2387–2397CrossRefGoogle Scholar
  88. 88.
    Kabara (1978)Google Scholar
  89. 89.
    Kabara JJ (1977) Fatty acids and derivatives of antimicrobial agents. US Patent 4,002,775Google Scholar
  90. 90.
    Google patents (Accessed February 2014)

Copyright information

© AOCS 2014

Authors and Affiliations

  1. 1.Department of ChemistryAteneo de Manila UniversityQuezon CityPhilippines

Personalised recommendations